Publication details
Analýza nákladů na 1. linii léčby metastatického kolorektálního karcinomu při podání režimů s bevacizumabem – data z reálné klinické praxe v České republice
| Title in English | The Cost Study of First- line Treatment of Metastatic Colorectal Carcinoma with Bevacizumab- containing Regimen in the Czech Republic |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| Web | http://www.linkos.cz/casopis-klinicka-onkologie/archiv/detail/cislo/2014-08-15-4/#wizard-layout-headline-3 |
| Field | Oncology and hematology |
| Keywords | drug costs; targeted molecular therapy; bevacizumab; antineoplastic agents; colorectal neoplasms |
| Description | The assessment of direct cost of bevacizumab in the treatment of mCRC in the first line therapy in Czech Republic. Cost were obtained from a comprehensive cancer center. Cost were assessed from intiation of treatment to progression disease and/or to death.The majority of the total costs was formed by targeted drug therapy. |